The Oxford PharmaGenesis Top 10 News Articles of 2018!

8 January 2019

We didn’t just sit on our haunches when we celebrated our 20th anniversary in January 2018. We’ve been busier than ever this year at Oxford PharmaGenesis! So, thank you to all our lovely clients and everyone who has helped 2018 to be another prize-winning year.

Below are the top 10 news articles of 2018 to feature on our website:

  1. Employees enjoy a healthy dose of celebration for the 20th anniversary of Oxford PharmaGenesis

Almost 200 Oxford PharmaGenesis colleagues from around the world gathered in Oxford to celebrate our first 20 years as an independent HealthScience consultancy! We captured the spirit in a memorable video

  1. Oxford PharmaGenesis hires Digital Communications Director

Our new Digital Communications Director joined us in the spring and we are excited about the new capabilities he brings to our growing in-house digital team.

  1. Oxford PharmaGenesis multi-team effort makes a great impact at the ISMPP Annual Meeting

We had a significant presence at the 14th Annual Meeting of the International Society for Medical Publication Professionals (ISMPP) in National Harbor, MD, USA. Our CEO, Chris Winchester, took over as Chair of the ISMPP Board of Trustees during the year, and we led multiple sessions as well as presented five posters of ground-breaking research.

  1. Oxford PharmaGenesis leads TIPPA US West Coast publications conference

For the second year, our Chief Operating Officer, Richard White, served as Chairman and led the 17th Annual Meeting of The International Publication Planning Association (TIPPA) in San Diego, CA, USA. He was ably supported by colleagues from our thriving US company.

  1. Oxford PharmaGenesis identified as one of the London Stock Exchange Group’s 1000 Companies to Inspire Britain

We were recognized, for the second year running, as one of the London Stock Exchange Group’s 1000 Companies to Inspire Britain – a proud achievement. This list identifies the fastest‑growing and most dynamic small- and medium-sized businesses across the UK and Europe. Oxford PharmaGenesis joined Oxford BioMedica, Immunocore, BrewDog and Time Out as top inspiring companies. Do read the full article, which includes a video of our CEO, Chris Winchester, discussing how Oxford PharmaGenesis works to inspire Britain and the world.

  1. Independent HealthScience specialist reaches the finals for top Communiqué award

We were delighted to reach the finals for the Communiqué Medical Education Consultancy of the Year award. Chris Winchester, CEO of Oxford PharmaGenesis, said: “This significant recognition from our peers in medical communications recognizes our industry leadership and our role in making a difference in the world: for patients, for our clients and for our employees.”

“This year, we not only celebrated our 20th birthday as an independent company, but we also grew by some 35% to over 220 experienced and energetic experts in Oxford, London, Cardiff, Basel, Melbourne and Philadelphia,” said Chris. “As a result, we can bring a global perspective to local challenges, and we are particularly proud of our award-winning HealthScience approach to demonstrating evidence-based pharmaceutical value for all our stakeholders. Our motto is ‘Powerful thinking, dedicated to your success’ and we live and breathe this every day to bring superlative personal service to every one of our clients.”

  1. PharmaGenesis Cardiff brings HealthScience to the Arab Health Congress

Another exciting conference for our HealthScience experts – PharmaGenesis Cardiff were pleased to introduce the concept of HealthScience communications to the Middle East Region.

  1. Exploring the evidence ecosystem: Oxford PharmaGenesis at ISMPP EU 2018

We continued to be active members of ISMPP throughout 2018 – this article summarizes our presence at the 2018 European Meeting of the International Society for Medical Publication Professionals (ISMPP).

  1. Celebrating #RareDiseaseDay: your questions on #RareDiseases answered

To support Rare Disease Day, our rare disease experts answered the questions we need to address to make progress in this very important area.

  1. Oxford PharmaGenesis trains mental health first-aiders

We work hard to ensure the well-being of our staff and are proud to have trained our first group of Oxford PharmaGenesis mental health first-aiders. This article summarizes what we learnt from the course and talks about other well-being activities we’ve arranged on both sides of the Atlantic.

And finally … Impressively, Oxford PharmaGenesis Inc. was voted Great Place to Work for the second year running: